COVID-19 Vaccine (inactivated, adjuvanted) Valneva European Union - English - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.

ERVEBO SOLUTION Canada - English - Health Canada

ervebo solution

merck canada inc - ebola zaÏre vaccine (rvsv [delta] g-zebov-gp, live) - solution - 72000000pfu - ebola zaÏre vaccine (rvsv [delta] g-zebov-gp, live) 72000000pfu

Qdenga European Union - English - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaccines - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age.the use of qdenga should be in accordance with official recommendations.

Abrysvo European Union - English - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiratory syncytial virus infections - vaccines - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. see sections 4.2 and 5.1.active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv.the use of this vaccine should be in accordance with official recommendations.

SMALLPOX VACCINE (DRIED) POWDER FOR SOLUTION Canada - English - Health Canada

smallpox vaccine (dried) powder for solution

sanofi pasteur limited - smallpox vaccine dried - powder for solution - 100m - smallpox vaccine dried 100m - vaccines

IMVAMUNE SUSPENSION Canada - English - Health Canada

imvamune suspension

bavarian nordic as - modified vaccinia virus (ankara-bavarian nordic) - suspension - 50000000ccid50 - modified vaccinia virus (ankara-bavarian nordic) 50000000ccid50 - vaccines

Liquid smallpox vaccine (live) VV Lister/CEP suspension 0.25ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

liquid smallpox vaccine (live) vv lister/cep suspension 0.25ml vials

live) vv lister/cep suspension 0.25ml vials (secretary of state for health - vaccinia virus live (lister strain) - liquid

COMIRNATY PBS Israel - English - Ministry of Health

comirnaty pbs

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - concentrate for dispersion for injection - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines - comirnaty is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 virus, in individuals 12 years of age and older.

SPIKEVAX Israel - English - Ministry of Health

spikevax

medison pharma ltd - cx-024414 mrna - dispersion for injection - cx-024414 mrna 1.26 mg/vial - covid-19 vaccines - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older.

Jynneos vaccine suspension for injection 0.5ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

jynneos vaccine suspension for injection 0.5ml vials

imported (united states) - vaccinia virus live (ankara strain, modified) - suspension for injection